About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer.
Leadership at Nkarta
The team at the top of the org chart.
Paul Hastings
President & CEO
93 reports
Fernando Buendia Laysa Jr.
Sr. Vice President, Head of Operations
54 reports
James Trager
Chief Scientific Officer
13 reports
SR
Shawn Rose MD
Chief Medical Officer and Head of Research and Development
13 reports
Ryan Kum
Executive Director Of Finance
6 reports
BH
Bridgette Housley
VP, General Counsel and Secretary
1 report
CM
Christine McCarrick
Executive Assistant To The CEO And CMO
Board
Mike Dybbs
Director
Dario Campana
Scientific Advisor
Leone Patterson
Board member and Audit Committee Chair
Lewis Lanier
Scientific Advisor
Ali Behbahani
Director
Angela Thedinga
Director